SCHEMBL19994579

SCHEMBL19994579

O=C(O)N1CCC(C=Cc2ccc(C(F)(F)F)cc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 8/20 0.57
▸ CYP1A2 P05177 1/20 0.46
▸ KCNH2 Q12809 1/20 0.46
▸ HRH3 Q9Y5N1 1/20 0.46
▸ HDAC3 O15379 1/20 0.43
▸ ADAM17 P78536 1/20 0.43
▸ HDAC1 Q13547 1/20 0.43
▸ HDAC2 Q92769 1/20 0.43
▸ HDAC10 Q969S8 1/20 0.43
▸ HDAC11 Q96DB2 1/20 0.43
▸ HDAC8 Q9BY41 1/20 0.43
▸ HDAC6 Q9UBN7 1/20 0.43
▸ HDAC5 Q9UQL6 1/20 0.43
▸ GAA P10253 2/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ GPR183 P32249 1/20 0.43
▸ MAOA P21397 1/20 0.42
▸ PAX8 Q06710 1/20 0.42
▸ LMNA P02545 1/20 0.41
▸ HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19994578 1.00 MAOB (0.57) MAOBCYP1A2KCNH2HRH3HDAC3
SCHEMBL21381915 0.86 CYP1A2 (0.49) MAOBCYP1A2KCNH2HRH3HDAC3
SCHEMBL27399366 0.85 TEAD1 (0.57) MAOBCYP1A2KCNH2HRH3HDAC3
SCHEMBL19994626 0.84 MAOB (0.61) MAOBMAOALMNAHPGDNOTUM
SCHEMBL19994629 0.84 MAOB (0.61) MAOBMAOALMNAHPGDNOTUM
SCHEMBL19994591 0.84 MAOB (0.55) MAOBGPR183MAOALMNA
SCHEMBL19994594 0.84 MAOB (0.55) MAOBGPR183MAOALMNA
SCHEMBL21381646 0.82 MAOB (0.54) MAOB
SCHEMBL14261790 0.82 MAOB (0.54) MAOB
SCHEMBL20015332 0.82 MAOB (0.54) MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3768684-A1 OXAZINE MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS F. Hoffmann-La Roche AG (CH) 2021-01-27 — — EP disclosed
WO-2019180185-A1 OXAZINE MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2019-09-26 — — WO disclosed
EP-3426634-A1 DISUBTITUTED AZETIDINES, PYRROLIDINES, PIPERIDINES AND AZEPANES AS INHIBITORS OF MONOAMINE OXIDASE B FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES University of Ljubljana (SI) 2019-01-16 — — EP disclosed
WO-2018055096-A1 DISUBTITUTED AZETIDINES, PYRROLIDINES, PIPERIDINES AND AZEPANES AS INHIBITORS OF MONOAMINE OXIDASE B FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES UNIVERSITY OF LJUBLJANA (SI) 2018-03-29 — — WO disclosed
Send feedback